Search clinical trials for: naloxon

Total 380 results

Didier Jutras Aswad
Canadian Institutes of Health Research (CIHR)

Completed

A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse (OPTIMA)

Opioid Use Disorder

Canada
Tanta University

Completed

Effect of Intrathecal Naloxone in the Incidence of Pruritis After C.S

Pruritis

Egypt
Kasr El Aini Hospital
Mansoura University

Completed

Influence Of Low Dose Intrathecal Naloxone On Bupivacaine - Fentanyl Spinal Anaesthesia For Lower Limb Orthopedic Surgery In Elderly Patients

Elderly | Anesthesia, Spinal

Egypt
Anders C Håkansson

Withdrawn

Naloxone to TReatment Entry in the Emergency Setting (N-TREE)

Substance Use Disorders | Opioid Dependence | Opioid Intoxication

Sweden
Hospices Civils de Lyon

Completed

Efficacy of Naloxone in Reducing Postictal Central Respiratory Dysfunction in Patients With Epilepsy (ENALEPSY)

Epilepsy

France
Mundipharma Korea Ltd

Completed

Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment

Low Back Pain

Korea, Republic of
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Unknown

Mechanisms of Hypoglycemia Associated Autonomic Failure

Diabetes Mellitus | Hypoglycemia | Autonomic Failure

United States
Wayne State University

Completed

Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence (BOS)

Heroin Dependence | Opioid Use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Human Immunodeficiency Virus | Opiate Dependence

Russian Federation
State University of New York at Buffalo

Completed

Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients

Low Back Pain

United States
Nassima Ait-Daoud Tiouririne

Unknown

Measures to Improve Outcomes After an Opioid Overdose

Opioid Overdose

United States
Norwegian University of Science and Technology
Oslo University Hospital; St. Olavs Hospital

Completed

Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital (NINA-1)

Overdose | Drug Abuse

Norway
Teva Pharmaceuticals USA

Withdrawn

An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.

Evaluation of QTc Interval
Vanderbilt University Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function

Chronic Pain

United States
RTI International
National Institute on Drug Abuse (NIDA)

Unknown

Preventing Opioid Overdose Mortality in the United States

Opioid Overdose

United States
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Intranasal Naltrexone and Naloxone

Opioid-use Disorder
Children's Mercy Hospital Kansas City

Completed

Comparison of Two Naloxone Infusion Rates on the Postoperative Recovery of Patients Undergoing Spine Fusion Surgery

Pain, Postoperative | Scoliosis | Postoperative Nausea and Vomiting

United States
University of Washington
American Heart Association

Completed

Nicotinamide Riboside in LVAD Recipients (PilotNR-LVAD)

Heart Failure，Congestive | Mitochondrial Alteration | Heart Failure New York Heart Association Class IV

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment

Opioid Use Disorder

United States
Drexel University

Completed

Addressing Overdose Risk Among Recently Incarcerated People Living With HIV/AIDS

Drug Overdose Accidental

United States
Washington University School of Medicine

Completed

Naloxone for Optimizing Hypoxemia Of Lung Donors (NO-HOLDS)

Brain Death | Lung Transplantation | Organ Donors

United States
Emory University
National Institute on Drug Abuse (NIDA); Chestnut Health Systems

Withdrawn

Adolescent Community Reinforcement Approach in Combination With Buprenorphine/Naloxone for Severe Opioid Use (A-CRA/MAT)

Behavior, Addictive | Opioid-Related Disorders
Edward Hospital

Completed

Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program

Opioid Use Disorder | Opioid Dependence

United States
University of Cincinnati
National Institute on Drug Abuse (NIDA)

Completed

A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses (TTIP-PRO)

Opioid-Related Disorders | Substance Abuse | Drug Overdose | Drug Abuse | Drug Addiction

United States
Viramal Limited

Completed

Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy

Endometriosis

Italy
Yale University
National Institute on Drug Abuse (NIDA); Howard University; George Mason University

Completed

HIV, Buprenorphine, and the Criminal Justice System (STRIDE)

Acquired Immunodeficiency Syndrome | Human Immunodeficiency Virus | Opiate Addiction | Drug Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Counseling for Primary Care Office-based Buprenorphine

Opiate Dependence

United States
Stony Brook University

Withdrawn

Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology

Opioid-use Disorder
University of Pennsylvania
Blue Cross Blue Shield; American College of Medical Toxicology

Completed

Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments

Opioid Use

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
Elysium Health
University of Pennsylvania

Unknown

Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET) (BestBet)

Recovery of Function

United States
Saskatchewan Health Authority - Regina Area
Gilead Sciences

Unknown

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy

Hepatitis C, Chronic | HIV/AIDS | Bone Diseases, Metabolic | Opioid Dependence | HIV-1-infection | HCV Coinfection | Buprenorphine Dependence | Methadone Dependence | Co-infection

Canada
University of Alabama at Birmingham

Withdrawn

Comparison of Three Opioid Detoxification Treatment Regimens

Opioid-Related Disorders | Opioid Withdrawal

United States
Regimmune Corporation

Completed

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Graft Versus Host Disease

United States
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

Pain | Cancer

China
Kaiser Permanente
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence

Opiate Substitution Treatment

United States
Finnish Institute for Health and Welfare

Completed

Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray (NALPILO)

Naloxone | Gambling | Spray | Opioid

Finland
Lifespan
University of Rhode Island

Completed

Medication Maintenance Therapy in Community Pharmacy Settings (MATPharm)

Opioid-use Disorder

United States
MedicaSafe, Inc.
Friends Research Institute, Inc.

Unknown

Improving Office Based Treatment of Opioid Use Disorder With Technology

Opioid-use Disorder

United States
State University of New York - Upstate Medical...
Binghamton University

Completed

A Usability Assessment of Naloxone Administration by Untrained Community Members

Harm Reduction | Opioid-use Disorder | Naloxone

United States
Finnish Institute for Health and Welfare

Unknown

Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder (NalGamb)

Naloxone | Gambling Disorder | Opioid Antagonist | Pathological Gambling

Finland
University of California, San Diego

Completed

The Role of Opioidergic Systems in Breathing Based Analgesia

Pain

United States
University of Vermont

Unknown

Interim Buprenorphine Treatment to Bridge Waitlist Delays: Stage II Evaluation

Opioid-use Disorder

United States
New York State Psychiatric Institute

Completed

Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse (PAIN)

Opioid Dependence

United States
Xiangya Hospital of Central South University

Completed

Treatment of Chronic Itch in Patients Under Arsenic Exposure With Sublingual Naloxone

Chronic Pruritus

China
Loyola University

Unknown

The Use of Oral Naloxone to Prevent Post Spinal Fusion Ileus (FusionIleus)

Ileus | Fusion of Spine

United States
Collegium Medicum w Bydgoszczy

Completed

Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine

Unstable Angina Pectoris

Poland
INSYS Therapeutics Inc

Completed

A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers

Healthy Volunteer

United States
INSYS Therapeutics Inc

Completed

A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers

Healthy Volunteer

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence

Opiate Dependence

United States

Search clinical trials for: naloxon

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations